Identification | Back Directory | [Name]
Opc-14523 monohcl | [CAS]
145969-31-9 | [Synonyms]
Opc-14523 monohcl OPC-14523 hydrochloride 1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-methoxy-3,4-dihydroquinolin-2-one | [Molecular Formula]
C23H29Cl2N3O2 | [MDL Number]
MFCD28157328 | [MOL File]
145969-31-9.mol | [Molecular Weight]
450.4 |
Hazard Information | Back Directory | [Uses]
OPC-14523 hydrochloride is an orally active sigma and 5-HT1A receptor agonist, with high affinity for sigma receptors (σ1/2 IC50=47/56 nM), the 5-HT1A receptor (IC50=2.3 nM), and the 5-HT transporter (IC50=80 nM). OPC-14523 hydrochloride shows antidepressant-like activity[1][2]. | [in vivo]
OPC-14523 hydrochloride (0.3-100 mg/kg; p.o.; daily for 0, 2, 4, 7 days) produces a marked antidepressant-like effect in the forced swimming test (FST) with rats and mice without affecting the general locomotor activity[1]. Animal Model: | Wistar strain of rats (140-245 g)[1] | Dosage: | 0.3-100 mg/kg | Administration: | P.o.; daily for 0, 2, 4, 7 days | Result: | A single doses of 1 mg/kg and higher of OPC-14523 reduced immobility time in the FST with an ED50 value of 27 mg/kg. The ED50 value for OPC-14523 on day 7 was 18 mg/kg.
|
Animal Model: | ICR strain of mice (25-45 g)[1] | Dosage: | 0.3-100 mg/kg | Administration: | P.o.; daily for 0, 2, 4, 7 days | Result: | A single oral dose of OPC-14523 produced a marked reduction in immobility time during the FST at oral doses of 1 mg/kg and higher, with an ED50 value of 20 mg/kg. The potency of OPC-14523 in decreasing immobility time was greater after treatment for seven consecutive days, producing an ED50 value of 2 mg/kg.
|
| [IC 50]
sigma 1: 47 nM (IC50); sigma 2: 56 mM (IC50); 5-HT1A Receptor: 2.3 nM (IC50) | [storage]
Store at -20°C | [References]
[1] Tottori K, et al. Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523. Neuropharmacology. 2001;41(8):976-988. DOI:10.1016/s0028-3908(01)00147-2 [2] Bermack JE, et al. Effects of the potential antidepressant OPC-14523 [1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone monomethanesulfonate] a combined sigma and 5-HT1A ligand: modulation of neuronal activity in the dorsa DOI:10.1124/jpet.104.066472 |
|
Company Name: |
MedChemExpress
|
Tel: |
021-58955995 |
Website: |
www.medchemexpress.com |
|